33 Kianmanesh AR, Perrin H, Panis Y, Fabre M, Nagy HJ, Houssin D, Klatzmann D. A“distant" bystander effect of suicide gene therapy: regression of nontransduced tumors together with a distant transduced tumor. Hum Gene Ther, 1997;8:1807-1814
34 Mullen CA, Anderson L, Woods K, Mishino M, Petropoulos D. Ganciclovir chemoablation of herpes thymidine kinase suicide gene-medified tumors produces tumors necrosis and induces systemic immune responses. Hum Gene Ther, 1998;9:2019-2030
35 Hall SJ, Sanford MA, Atkinson G, Chen SH. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer. Cancer Res, 1998;58:3221-3225
36 Morinchi S, Oligino T, Krisky D, Marconi P, Fink D, Cohen J, Glorioso JC. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase. Cancer Res, 1998;58:5731-5737
37 Caruso M, Panis Y, Singh G, Houssin D, Salzmann JL, Klatzmann D. Regression of an established macroscopic liver tumor by in vivo retroviral-mediated transfer of a suicide gene. Proc Natl Acad Sci, 1993;90:7024-7028
38 Kwong YL, Chen SH, Kosai K, Finegold MJ, Woo SI. Adenoviral_mediated suicide gene therapy for hepatic metastases of breast. Cancer, 1996;3:339-344
39 Nagy H, Panis Y, Fabre M, Perrin H, Klatzmann D, Houssiin D. Are hepatoma a good target for suicide gene therapy An experimental study in rat using retroviral-mediated transfer of thymidine kinase gene. Surgery, 1998;123:19-24
40 Ueki T, Nakata K, Mawatari F, Tsuruta S, Ido A, Ishikawa H, Nakao K. Retrovirus-mediated gene therapy for human hepatocellular carcinoma tranplanted in athymic mice. Int J Mol Med, 1998;1:671-675
41 Mawatari F, Tsuruta S, Ido Ueki T, Nakao K, Kato Y, Tamaoki T. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promotor. Cancer Gene Res, 1998;5:301-306
42 Gerolami R, Cardoso J, Bralet MP, Cuenod CA, Clement O, Tran PL, Brechot C. Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery. Gene Ther, 1998;5:896-904
43 Link CJ Jr, Levy JP, McCann LZ, Moorman DW. Gene therapy for colon cancer with the herpes simlex thymidine kinase gene. J Surg Oncol, 1997;64:289-294
44 Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D. Mechanism for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene. Clin Cancer Res, 1998;4:731-741
45 McMaster RA, Saylors RL, Jones KE. Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation. Hum Gene Ther, 1998;9:2253-2261
46 Ohashi M, Kanai F, Tanaka T, Lan KH, Shiratori Y, Komatsu Y, Kawabe T. In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-prodrug pancreatic cancer. Jpn J Cancer Res, 1998;89:457-462
47 Rosenfeld ME, Vicker SM, Raben D, Wang M, Sampson L, Feng M, Jaffee E. Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene. Ann Surg, 1997;225:609-618
48 Aoki K, Yoshida T, Matsumoto N, Ide H, Hosokawa K, Sugimura T, Terada M. Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated trandfer of herpes simplex virus thymidine kinase gene. Hum Gene Ther, 1997;8:1105-1113
49 Yoshida K, Kawami H, Yamaguchi Y, Kuniyasu H, Nishiyama M, Hirai T, Yanagihara K. Retrovirally transmitted gene therapy for gastric carcinoma using herpes simplex virus thymidine kinase gene. Cancer, 1995;75(6 Suppl):1467-1471
50 Tanaka T, Kanai F, Lan KH, Ohashi M, Shiratori Y, Yoshida Y, Hamada H. Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo. Biochem Biophys Res Commun, 1997;231:775-779
51 Klatzmann D, Valery CA, Bensimon G, Marro B, Boyer O, Mokhtari K, Diguet B. A phase Ⅰ/Ⅱ Study of herpes simplex virus type 1 thymidine kinase “suicide" gene therapy for recurrent glioblastoma. Hum Gene Ther, 1998;9:2595-2604
52 Sterman DH, Treat J, Litzky LA, Amin KM, Coonrod L, Molnar-Kimber K, Recio A. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase Ⅰ clinical trial in malignant mesothelioma. Hum Gene Ther, 1998;9:1083-1092